QCM
ENTA icon

Quantinno Capital Management’s Enanta Pharmaceuticals ENTA Stock Holding History

Quantinno Capital Management’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$658K Buy
45,109
+9,987
+28% +$134K ﹤0.01% 2835
2026
Q1 		$444K Buy
35,122
+1,627
+5% +$21.8K ﹤0.01% 2799
2025
Q4 		$528K Sell
33,495
-3,631
-10% -$46.1K ﹤0.01% 2367
2025
Q3 		$444K Buy
37,126
+24,785
+201% +$198K ﹤0.01% 2123
2025
Q2 		$93.3K Buy
12,341
+1,324
+12% +$7.96K ﹤0.01% 2518
2025
Q1 		$60.8K Buy
+11,017
New +$68.1K ﹤0.01% 2078

Other funds holding ENTA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Quantinno Capital Management's ENTA Position: Q2 2026 in Review

Quantinno Capital Management increased its Enanta Pharmaceuticals (ENTA) stake by 28% in Q2 2026, buying an estimated $134K and bringing the position to 45,109 shares worth $658K. The position accounts for ﹤0.01% of the portfolio, ranked #2835.

Quantinno Capital Management first reported a position in ENTA in Q1 2025 and has held it in 6 quarters since. 123 funds tracked by Wall St. Rank hold ENTA as of Q2 2026.

  • Quantinno Capital Management held 45,109 shares of Enanta Pharmaceuticals worth $658K as of Q2 2026.
  • Quantinno Capital Management bought 9,987 Enanta Pharmaceuticals shares in Q2 2026, an estimated $134K.
  • Enanta Pharmaceuticals made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #2835 holding.
  • Quantinno Capital Management first reported a position in Enanta Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 123 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.